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Abstract 
Background: The number of intensive care patients aged ≥ 80 years (Very old Intensive Care Patients; VIPs) is grow-
ing. VIPs have high mortality and morbidity and the benefits of ICU admission are frequently questioned. Sepsis 
incidence has risen in recent years and identification of outcomes is of considerable public importance. We aimed to 
determine whether VIPs admitted for sepsis had different outcomes than those admitted for other acute reasons and 
identify potential prognostic factors for 30-day survival.
Results: This prospective study included VIPs with Sequential Organ Failure Assessment (SOFA) scores ≥ 2 acutely 
admitted to 307 ICUs in 21 European countries. Of 3869 acutely admitted VIPs, 493 (12.7%) [53.8% male, median age 
83 (81–86) years] were admitted for sepsis. Sepsis was defined according to clinical criteria; suspected or demon-
strated focus of infection and SOFA score ≥ 2 points. Compared to VIPs admitted for other acute reasons, VIPs admit-
ted for sepsis were younger, had a higher SOFA score (9 vs. 7, p < 0.0001), required more vasoactive drugs [82.2% vs. 
55.1%, p < 0.0001] and renal replacement therapies [17.4% vs. 9.9%; p < 0.0001], and had more life-sustaining treat-
ment limitations [37.3% vs. 32.1%; p = 0.02]. Frailty was similar in both groups. Unadjusted 30-day survival was not 
significantly different between the two groups. After adjustment for age, gender, frailty, and SOFA score, sepsis had no 
impact on 30-day survival [HR 0.99 (95% CI 0.86–1.15), p = 0.917]. Inverse-probability weight (IPW)-adjusted survival 
curves for the first 30 days after ICU admission were similar for acute septic and non-septic patients [HR: 1.00 (95% CI 
0.87–1.17), p = 0.95]. A matched-pair analysis in which patients with sepsis were matched with two control patients 
of the same gender with the same age, SOFA score, and level of frailty was also performed. A Cox proportional hazard 
regression model stratified on the matched pairs showed that 30-day survival was similar in both groups [57.2% (95% 
CI 52.7–60.7) vs. 57.1% (95% CI 53.7–60.1), p = 0.85].
Conclusions: After adjusting for organ dysfunction, sepsis at admission was not independently associated with 
decreased 30-day survival in this multinational study of 3869 VIPs. Age, frailty, and SOFA score were independently 
associated with survival.
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Introduction
The proportion of patients aged ≥ 80  years admitted to 
intensive care units (ICU), so-called Very Old Intensive 
Care Patients (VIPs), is growing fast due to ageing of the 
population [1]. Nowadays, VIPs represent 10% to 20% of 
all ICU admissions [2–7].
Infection is one of the most frequent reasons for acute 
ICU admission of older patients, with increasing inci-
dences over the last decades [8–13]. Sepsis develops 
when the host’s response to infection becomes dysregu-
lated and leads to life-threatening organ dysfunction 
[14]. Older patients account for a small proportion of the 
overall population, but a large proportion of sepsis cases; 
about 60% of septic patients are aged > 65 years. The inci-
dence of sepsis increases with age and increases steeply 
in persons aged ≥ 80  years [8–10]. Very old persons are 
at particularly high risk due to pre-existing comorbidi-
ties, impaired immune function (immunosenescence), 
sarcopenia, decrease in reserve capacities related to age-
ing, and many times malnutrition and polypharmacy 
[8–10, 15]. Moreover, mortality rates in VIPs with sepsis 
are high, with an estimated ICU mortality of 50% to 60% 
[6], reaching 92% at 6  months in those with circulatory 
failure [16]. In addition, survivors are at increased risk of 
developing cognitive impairment and functional disabili-
ties, estimated at 16% to 40% [17–19].
The relatively high risk of mortality and shorter life 
expectancy amongst VIPs with sepsis, combined with 
increasing pressure on healthcare facilities including 
ICUs, result in uncertainty about the appropriateness of 
admitting VIPs with sepsis to ICUs, especially if they are 
frail or have severe comorbidities. Given the goal of long-
term survival with a satisfactory quality of life (QoL) 
according to patients’ expectations, it is often difficult to 
predict the benefits of ICU treatment in VIPs, [19, 20]. 
To determine whether VIPs with sepsis should be admit-
ted to ICUs, healthcare providers need more information 
about outcomes and risk factors [21].
We aimed to determine whether VIPs admitted with 
sepsis had a different 30-day outcome than VIPs admit-
ted for other acute reasons and to identify potential prog-
nostic factors for 30-day survival.
Materials and methods
Study design and setting
The present study is a post-hoc analysis of the VIP1 mul-
tinational cohort study [1]. Patients with sepsis were 
identified as a group of interest and before the end of 
the VIP1 study, we decided to analyse the cohort of VIPs 
admitted for sepsis versus VIPs admitted for another 
acute reason.
In brief, the VIP1 study was a prospective observational 
study to measure outcomes in patients aged ≥ 80  years 
in 311 ICUs in 21 European countries. Each participat-
ing ICU included the first consecutive 20 VIPs admitted 
within a 3-month inclusion period; data were collected 
between October 2016 and May 2017. A website was 
designed to provide information about the study and to 
enable data entry using an electronic case record form; 
the electronic case record form and database ran on a 
secure server at Aarhus University, Denmark. The study 
was registered at ClinicalTRials.gov (ID: NCTO3134807).
Participants
From the original VIP1 study, only acute admissions in 
patients ≥ 80  years of age were eligible. We excluded 
patients admitted for postoperative care after planned 
surgery; all the other 11 reasons for acute ICU admis-
sions were accepted (Additional file 1: Table S1).
Study variables and data collection
Demographic and clinical characteristics were recorded 
for all patients, including age, gender, hospital length of 
stay (LOS) prior to ICU admission, LOS in ICU, SOFA 
score at admission [22], and frailty measured with the 
Clinical Frailty Scale (CFS) [23].
The main outcome variable was survival in the 30 days 
following ICU admission. We also recorded the use of the 
following: invasive mechanical ventilation, non-invasive 
ventilation, vasoactive drugs, renal replacement therapies 
(RRT), and orders to withhold or withdraw life-sustain-
ing treatment (LST).
Definitions
Admission categories
The most appropriate clinical reason for ICU admission 
was chosen by the site investigator from a predefined 
list of 11 acute categories (respiratory failure, circulatory 
failure, combined respiratory/circulatory failure, sepsis, 
severe trauma without head injury, severe trauma with 
head injury, isolated head injury, intoxication, non-trau-
matic brain injury, postoperative care after emergency 
surgery, or other) (Additional file 1: Table S1).
Severe sepsis admission category
Patients were included in sepsis category according to 
clinical criteria.
Keywords: Sepsis, Very old, Intensive care, Severity of illness, Outcome, Survival, Mortality
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Clinical criteria adopted since 2015 are ¨suspected or 
documented infection and an acute increase of ≥ 2 SOFA 
points (a proxy for organ dysfunction) ¨. It was updated 
in 2016 in sepsis-3 criteria [14]: ¨Sepsis is a life-threat-
ening organ dysfunction caused by a dysregulated host 
response to infection. For clinical operationalisation, 
organ dysfunction can be represented by an increase in 
the Sequential [Sepsis-related] Organ Failure Assessment 
(SOFA) score of 2 points or more, which is associated 
with a in-hospital mortality greater than 10%”.
Frailty
It was assessed according to the Clinical Frailty Scale 
[23]. This scale is composed of nine classes from very fit 
to terminally ill (Additional file 2: Figure S1). We deter-
mined the frailty level present before hospital admission 
and not affected by the acute illness. Patients were classi-
fied according to the CFS as “fit” (CFS ≤ 3), “vulnerable” 
(CFS = 4), or “frail” (CFS ≥ 5).
Statistical analysis
No formal sample-size calculation was performed for 
this observational study. Nevertheless, with the number 
of subjects included in our sample, to test whether the 
hazard ratio of septic vs non-septic patients is equal to 
1.5, the power is 99. To test whether survival of septic is 
equivalent to that of non-septic patients, the power is 99.
We compared baseline characteristics, treatment, 
and outcomes between septic and non-septic VIPs. We 
expressed categorical variables as frequencies and per-
centages, and continuous variables as medians and inter-
quartile ranges. There are no missing values amongst the 
variables used in the analysis, except for 2 patients with 
missing date of ICU discharge. To compare groups, we 
used Chi square tests for categorical variables and the 
Mann–Whitney U test for continuous variables.
To study 30-day survival, all patients were censored at 
day 30. For patients discharged from the ICU and dead 
at day 30, the precise date of death is unknown; for those, 
we assumed that the survival time was the middle of the 
interval between date of discharge and day 30. This mid-
point imputation is a simple method to deal with inter-
val-censored data and has been shown to give similar 
estimates than more advanced methods [24].
Unadjusted survival curves were estimated using 
the standard Kaplan–Meier estimator and compared 
between groups by means of a log-rank test.
To estimate associations between variables and survival 
30 days after ICU admission, we used a Cox proportional 
hazard regression model. To check the proportional-
ity assumption for each covariate, we plotted the scaled 
Schoenfeld residuals against time along with smooth 
curves and detected no violation of the assumption. 
Inverse probability weights (IPW) were used to produce 
survival curves adjusted for covariates [25]. The weights 
were estimated using the same covariates included in the 
Cox model, namely frailty, age, gender, type of admis-
sion (septic vs. non-septic), and SOFA score to estimate 
the weights. Informally, each subject is weighted by the 
inverse of the probability of having sepsis or not condi-
tionally on the covariates.
We also performed a matched-pair analysis. For each 
septic patient, we identified a non-septic patient of the 
same age, gender, level of frailty, and an SOFA score equal 
to that of the septic patient plus or minus 0.1. To estimate 
associations between sepsis and survival at 30 days after 
ICU admission in the matched sample, we used a Cox 
proportional hazard regression model stratified on the 
matched pairs. We plotted the Kaplan–Meier survival 
curves of septic and non-septic patients in the matched 
sample and used the usual log-rank test to compare the 
curves [26].
P values less than 0.05 were considered statistically sig-
nificant. All analyses were performed with R software, 
version 3.2.2 (R foundation for Statistical computing).
Results
Participants
The VIP1 study included 5132 VIPs; 5021 (98%) com-
pleted the 30-day follow-up. Amongst patients who com-
pleted the 30-day follow-up, we excluded the 906 (18%) 
admitted primarily for postoperative care after elec-
tive surgery. Moreover, we excluded 246 (4.9%) patients 
with Sequential (Sepsis-related) Organ Failure Assess-
ment (SOFA) score < 2; thus, we analysed data from 3869 
patients (Fig.  1). Regions and countries of the included 
patients are listed (Additional file 3: Table S2).
Patient characteristics
We included 3869 VIPs [median age 84 (82–86) years; 
2013 (52%) male; median SOFA score 8 (5–11); 47% 
frail; 32.8% with limitations on LST] admitted as acute 
patients to 307 ICUs in 21 countries in the context of the 
multicentre VIP-1 study. LOS before ICU was 1 day (0–3) 
(see Table 1).
The median number of patients recruited per coun-
try was 143 (range 3–719), and the median number of 
patients per ICU was 13 (range 1–67).
Comparison between VIPs admitted for sepsis and those 
admitted for other acute reasons
Patients admitted for sepsis accounted for 12.7% 
(493/3869); there was no gender difference, but the sepsis 
group were younger, had a higher SOFA score on admis-
sion, more often received vasoactive drugs and RRT, but 
were less frequently given mechanical ventilation and 
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Fig. 1 Study flowchart. VIP1 study [1]. Septic patients: patients admitted to ICU for sepsis; non-septic patients: patients admitted to ICU for another 
acute reason. SOFA Sequential Organ Failure Assessment
Table 1 Comparison of acute patients admitted for sepsis versus acute patients admitted for other reason
LOS length of stay, SOFA Sequential Organ Failure Assessment, CFS Clinical Frailty Scale, RRT renal replacement therapy, LST Life-sustaining treatment
a Expressed as median, IQR
No missing values except for length of ICU stay; 2 patients had a missing date of discharge
Admission category All acute patients Other categories Sepsis p value
N (%) 3869 (100%) 3376 (87.3%) 493 (12.7%)
Age (years)a 84 (82–86) 84 (82–87) 83 (81–86) < 0.0001
Gender (male) 2013 (52%) 1748 (51.8%) 265 (53.8%) 0.4402
Hospital LOS before ICU (days)a 1 (0–3) 1 (0–3) 1 (0–3) 0.4600
SOFA score at  admissiona 8 (5–11) 7 (5–11) 9 (6–12) < 0.0001
ICU LOS (days)a 2.96 (1.17–6.81) 2.88 (1.12–6.67) 3.54 (1.5–8) 0.0036
Frailty (CFS)
 Fit (CFS 1–3) 1331 (34.4%) 1166 (34.5%) 165 (33.5%) 0.0737
 Vulnerable (CFS 4) 719 (18.6%) 643 (19%) 76 (15.4%)
 Frail (CFS 5–9) 1819 (47%) 1567 (46.4%) 252 (51.1%)
 Fit or vulnerable 2050 (53%) 1809 (53.6%) 241 (48.9%) 0.0568
Frail 1819 (47%) 1567 (46.4%) 252 (51.1%)
Interventions in ICU
 At least 1 intervention 3196 (82.6%) 2760 (81.8%) 436 (88.4%) 0.0003
 No interventions 673 (17.4%) 616 (18.2%) 57 (11.6%)
 Mechanical ventilation 2087 (53.9%) 1853 (54.9%) 234 (47.5%) 0.0024
 Non-invasive ventilation 1047 (27.1%) 939 (27.8%) 108 (21.9%) 0.0069
 Vasoactive drugs 2265 (58.5%) 1860 (55.1%) 405 (82.2%) < 0.0001
 RRT 421 (10.9%) 335 (9.9%) 86 (17.4%) < 0.0001
Life-sustaining treatment limitations
 No LST limitations 2601 (67.2%) 2292 (67.9%) 309 (62.7%) 0.0243
 LST limitations 1268 (32.8%) 1084 (32.1%) 184 (37.3%)
 Withholding 679 (17.5%) 571 (16.9%) 108 (21.9%) 0.0196
 Withdrawing ± withholding 589 (15.2%) 513 (15.2%) 76 (15.4%)
Outcome
 ICU mortality 1072 (27.7%) 918 (27.2%) 154 (31.2%) 0.0686
 30-day mortality 1577 (40.8%) 1357 (40.2%) 220 (44.6%) 0.0687
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NIV. Limitations of life-sustaining treatment (LST) were 
more frequently performed, and LOS was increased in 
patients admitted with sepsis (Table 1).
Unmatched analysis
No significant differences between groups were observed 
in survival after ICU admission (p = 0.1); survival at day 4 
was 78.2% (95% CI 74.6–82.0) in septic patients vs. 82.8% 
(95% CI 81.5–84.1) in non-septic patients and survival at 
day 30 was 54.8% (95% CI 50.5–59.5) in septic patients 
vs. 57.8% (95% CI 56.1–59.5) in non-septic VIPs; HR for 
septic vs. non-septic patients was 1.13 (95% CI 0.98–1.3), 
p = 0.0986. After adjustment for age, frailty, gender, and 
SOFA score, sepsis had no effect on survival after ICU 
admission [HR: 0.99 (95% CI 0.86–1.15), p = 0.917] 
(Table 2A).
Inverse-probability weight (IPW)-adjusted survival 
curves for the first 30 days after ICU admission were sim-
ilar for septic and non-septic patients [HR: 1.00 (95% CI 
0.87–1.17), p = 0.947] (Fig. 2b).
Inverse-probability weight (IPW) survival curves for 
quartiles of the SOFA score in septic and non-septic 
patients showed no significant differences (Additional 
file 4: Figure S2).
Matched analysis
Likewise, 30-day survival in the matched sample (443 
septic patients vs. 824 patients without sepsis, 62 patients 
had only one match and 55 could not be matched—
Table 3) was similar in septic and non-septic VIPs [57.2% 
(95% CI 52.7–60.7) vs. 57.1% (95% CI 53.7–60.1); HR: 
1.02 (95% CI 0.85–1.22), p = 0.854] (Fig. 2c).
Prognostic factors of survival in all acute admitted patients
In the multivariate analysis, age, frailty, and SOFA score 
were independently associated with survival, but sepsis 
was not (Table 2A).
Separate analyses for septic and non-septic patients 
yielded similar results (Table 2B, C).
A possible centre effect was assessed comparing the 
log partial likelihood of a model including only sepsis 
and that of the same model integrating a random centre 
effect. The p value for the random effect was < 0.001 sug-
gesting a significant random effect across centre. We thus 
built a Cox model using the same variables and integrat-
ing a random centre effect. The coefficients and degree of 
significance of the parameters are comparable to those 
of the model without random effect (Additional file  5: 
Table S3).
Discussion
We found that the 30-day survival rate in patients with 
sepsis was similar to the survival of patients admitted for 
another acute reason. Sepsis, after adjusting for organ 
dysfunction, did not significantly influence. Age, frailty, 
and SOFA score were the independent factors associated 
Table 2 Factors affecting 30-day survival of  ICU patients aged ≥ 80  years with  SOFA ≥ 2 at  admission, multivariate 
analysis
HR (95% CI) p value
A. Results of the Cox analysis considering all acutely admitted patients (n = 3869)
 Sepsis 0.99 (0.86–1.15) p = 0.9173
 Age (per 5-year increase) 1.16 (1.09–1.25) p < 0.0001
 Frailty: vulnerable vs. fit 1.16 (1–1.35) p = 0.0556
 Frailty: frail vs. fit 1.47 (1.31–1.66) p < 0.0001
 Male vs. female 1.16 (1.05–1.28) p = 0.0043
 SOFA score (per one-point increase) 1.13 (1.12–1.14) p < 0.0001
B. Results of the Cox analysis considering only acute patients admitted for sepsis (n = 493)
 Age (per 5-year increase) 1.33 (1.1–1.61) p = 0.0029
 Frailty: vulnerable vs. fit 1.54 (1.02–2.34) p = 0.0416
 Frailty: frail vs. fit 1.47 (1.07–2.02) p = 0.0182
 Male vs. female 1.12 (0.85–1.47) p = 0.4202
 SOFA score (per one-point increase) 1.13 (1.1–1.17) p < 0.0001
C. Results of the Cox analysis considering only acute patients admitted for other reason than sepsis (n = 3376)
 Age (per 5-year increase) 1.14 (1.06–1.23) p = 0.0005
 Frailty: vulnerable vs. fit 1.11 (0.95–1.31) p = 0.1939
 Frailty: frail vs. fit 1.48 (1.31–1.68) p < 0.0001
 Male vs. female 1.16 (1.04–1.3) p = 0.0064
 SOFA score (per one-point increase) 1.13 (1.12–1.14) p < 0.0001
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Fig. 2 Kaplan–Meyer survival curves in septic and acute non-septic patients. a Non-adjusted. b Inverse-probability weight (IPW)-adjusted overall 
survival (the weights were estimated using frailty, age, gender, type of admission, and SOFA score). c Matched cohort survival analysis
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with 30-day survival in patients admitted to ICU for sep-
sis, similar to all acute VIPs with SOFA ≥ 2. This prob-
ably indicates that severity of illness (as expressed by the 
SOFA score) is the factor that predicts survival indepen-
dently of whether it is due to sepsis or to other reasons. 
Therefore, admission for sepsis should not be a factor to 
limit an ICU admission in this old population.
We collected data from a large cohort in 307 ICUs 
from 21 European countries. Sepsis was the main rea-
son for admission in 12.7% of the VIPs, a rate similar to 
those reported in previous studies (9–12%) [8, 15, 19, 
20, 27]. Our sample was slightly different to the one ana-
lysed in the original VIP1 study, because we excluded 
the subgroup of patients admitted after planned surgery 
and compared all acute admissions with the sepsis sub-
group. This might explain changes in the results, and in 
the significance of the lack of variable gender in the pre-
sent analysis. The original VIP1 paper was designed to 
study the occurrence of frailty and to assess its impact 
on 30-day mortality in patients 80 years of age or older 
admitted to European ICUs. The secondary objective was 
to report the intensity of care and treatment restrictions 
whilst in the ICU in this patient group. The original VIP-1 
study demonstrated an inverse relation between frailty 
and 30-day mortality and high mortality rates for VIPs 
admitted to the ICU with sepsis. We studied and better 
characterised the subgroup of very old septic patients, 
identifying the variables associated with outcome, rein-
forcing that frailty and severity of illness (SOFA) as well 
as age, and are the determinant factors affecting outcome 
in VIPs admitted for sepsis. Moreover, we confirmed that 
sepsis at admission was not a determinant factor on out-
come in this population with the analysis of a matched 
sample with septic and non-septic patients.
Our results are important because relatively few well-
designed studies have addressed the impact of sepsis in 
older patients. Reported ICU-survival rates amongst 
octogenarians with sepsis vary widely [6, 16, 27, 28], and 
the risk factors for mortality in these patients have not 
been completely elucidated. A recent systematic review 
including 4256 patients aged ≥ 80  years from 18 stud-
ies [29] reported mortality rates of 43% in the ICU, 47% 
in the hospital, and 68% 1 year after ICU admission. 
Reported rates for 30-day mortality range from 30 [27] to 
50% [6, 29].
To our knowledge, this is the first study to compare 
frequencies of therapeutic interventions, limitations on 
life-supporting treatments, risk factors for mortality, and 
outcomes between VIPs admitted with sepsis and those 
admitted for other acute reasons. In the present study, 
elective surgical patients were excluded because various 
other publications [23, 28–32] demonstrated that such 
patients have a better outcome with much lower mortal-
ity rates.
Previous studies reported that limitations on life-
sustaining treatment were applied more frequently and 
earlier in aged patients than in younger patients [27], 
and moreover, limitations on LST often preceded VIPs’ 
death in the ICU [27, 33, 34]. However, the intensity 
of treatment in VIPs has increased over time, and this 
increase has been associated with a decrease in mor-
tality adjusted for severity [3]. The incidence of LST 
limitations reported in recent studies ranges from 10 to 
27%, being higher in aged patients and reaching 41.6% 
in very old, frail patients [33–36]. Guidet et  al. [37] 
studied decisions to limit LST in the VIP-1 cohort and 
demonstrated that acute admission, frailty, age, SOFA 
score at admission, and country were associated with 
the application of limitations. We found that patients 
admitted for sepsis received more therapeutic interven-
tions, mainly vasoactive drugs and RRT. Decisions to 
Table 3 Description of the matched sample
443 patients with sepsis were matched to 824 patients without sepsis
62 patients had only one match and 55 could not be matched
Survival was similar; sepsis HR 1.02 (95% CI 0.85–1.22), p = 0.854
LOS length of stay, SOFA Sequential Organ Failure Assessment, CFS Clinical Frailty 
Score, RRT renal replacement therapy, LST life-sustaining treatment
a Expressed in median, IQR
Admission category Other categories Sepsis p value
N 824 443
Age (years)a 82 (81–85) 83 (81–85) 0.5618
Gender (male) 435 (52.8%) 233 (52.6%) 0.9941
Hospital LOS before ICU 
admission (days)a
1 (0–3) 1 (0–3) 0.28
SOFA score at 
 admissiona
8 (6–11) 8 (6–12) 0.5468
ICU LOS (days)a 3.29 (1.33–7.85) 3.88 (1.67–8.53) 0.2454
Frailty (CFS) 0.6963
Fit (CFS 1–3) 273 (33.1%) 144 (32.5%)
Vulnerable (CFS 4) 105 (12.7%) 64 (14.4%)
Frail (CFS 5–9) 446 (54.1%) 235 (53%)
Therapeutic interventions in ICU
At least one 723 (87.7%) 389 (87.8%) 0.999
Mechanical ventilation 480 (58.3%) 202 (45.6%) < 0.0001
Non-invasive ventilation 239 (29%) 100 (22.6%) 0.0164
Vasoactive drugs 500 (60,7%) 361 (81.5%) < 0.0001
RRT 115 (14%) 77 (17.4%) 0.1238
Life-sustaining treatment limitations
No LST limitations 568 (68.9%) 286 (64.6%) 0.1284
LST limitations 256 (31.1%) 157 (35.4%)
Withholding 128 (15.5%) 98 (22.1%) 0.0124
Withdrawing ± with-
holding
128 (15.5%) 59 (13.3%)
ICU mortality 239 (29%) 126 (28.4%) 0.8841
30-day mortality 337 (40.9%) 187 (42.2%) 0.6942
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limit LST (mainly as withholding therapy) were more 
common in septic patients (22% vs 17%) and this could 
be explained because they were frailer and had more 
organ dysfunction.
Our study’s strengths include its large prospective 
sample, multicentre design, international participa-
tion, and acutely admitted non-septic control group. 
Furthermore, recruiting all patients prospectively in a 
period of 8 months reduced time bias.
Our study, however, has several limitations. First, 
data in VIP1 study were prospectively collected [1] but 
the data analysis on septic patients was retrospectively 
done after closure of the database of the original study. 
Second, admission categories were mutually exclusive 
and the site investigator in every centre decided to 
include the patient in one or another category accord-
ing to the main diagnosis. Severe sepsis was defined 
according to clinical criteria [14] and we must assume 
that the individual ICUs appropriately used this defi-
nition. However, we cannot fully exclude that some 
patients may have been misclassified, for example as 
acute circulatory or respiratory failure. In other words, 
patients with acute or respiratory failure may also have 
had a sepsis.
Third, we were not able to analyse the subgroup of 
patients with septic shock since lactate levels were not 
available in the registry. Anyhow, 82.2% of the septic 
patients received vasopressors to maintain a mean arte-
rial pressure of 65 mmHg and mean SOFA at admission 
was 9. Fourth, the focus of infection was not registered 
and occurrence of sepsis after ICU admission was nei-
ther reported. Fifth, we have no data about patients 
who were not admitted to the ICU due to triage deci-
sions. Sixth, we did not analyse reasons for LST limi-
tations, because it was not the aim of the study, it is 
fully analysed in another article [36]. Seventh, the only 
datum about prior health status recorded was frailty, so 
no information about comorbidities or previous cogni-
tive status was available. And last, no follow-up of the 
patients was performed.
Nevertheless, our results provide insight into the out-
come and factors associated with 30-day survival in VIPs 
admitted for sepsis in comparison to VIPs admitted for 
other acute reasons. The fact that sepsis at admission, 
after adjusting for organ dysfunction, was not indepen-
dently associated with survival suggests that the best 
option today is assessing very old patients according to 
their age, frailty, and severity of illness, independently of 
their diagnostic category. Once admitted to ICU, we can 
establish goals of care and reassess the intensity of thera-
peutic interventions after a reasonable period of time, 
according to response to treatment, expected outcomes, 
and patient/family wishes [38].
Conclusion
Mortality 30 days after ICU admission is high in very old 
patients admitted with sepsis. However, we did not find 
admission for sepsis to be an independent risk factor for 
decreased survival. Frailty, older age, and higher SOFA 
score at admission were the significant factors associated 
with decreased 30-day survival in this population. There-
fore, sepsis at admission should not be the only determin-
ing factor either in the decision of admission to the ICU 
or in the establishment of LST in very elderly patients.
Future research is required to optimise care for these 
patients. We also need more information about long-
term survival and quality of life in VIPs admitted for sep-
sis and a reliable risk prediction model.
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